Covidien PLC (COV) financial statements (2020 and earlier)

Company profile

Business Address 20 ON HATCH
DUBLIN, DUBLIN 2
State of Incorp.
Fiscal Year End September 30
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2014
9/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,5671,868
Cash and cash equivalents1,5671,868
Receivables1,5321,526
Inventory, net of allowances, customer advances and progress billings1,4081,352
Inventory1,4081,352
Derivative instruments and hedges, assets70 
Income taxes receivable5562
Other undisclosed current assets8221,059
Total current assets:5,4545,867
Noncurrent Assets
Property, plant and equipment2,0242,012
Intangible assets, net (including goodwill)12,13310,859
Goodwill8,8518,172
Intangible assets, net (excluding goodwill)3,2822,687
Other noncurrent assets810805
Other undisclosed noncurrent assets280375
Total noncurrent assets:15,24714,051
TOTAL ASSETS:20,70119,918
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,1991,616
Accounts payable501501
Employee-related liabilities495426
Taxes payable203689
Debt1,00911
Derivative instruments and hedges, liabilities8 
Deferred tax liabilities125
Other liabilities1,7181,586
Other undisclosed current liabilities(658)(579)
Total current liabilities:3,2882,639
Noncurrent Liabilities
Long-term debt and lease obligation, including:4,0355,018
Other undisclosed long-term debt and lease obligation4,0355,018
Liabilities, other than long-term debt2,7362,461
Accrued income taxes9871,147
Deferred tax liabilities, net679605
Restructuring reserve3313
Other liabilities1,037696
Other undisclosed noncurrent liabilities522558
Total noncurrent liabilities:7,2938,037
Total liabilities:10,58110,676
Temporary equity, carrying amount60 
Stockholders' equity
Stockholders' equity attributable to parent10,0609,242
Common stock9197
Treasury stock, value(139)(2,210)
Additional paid in capital7,8427,549
Accumulated other comprehensive income145292
Retained earnings2,1213,514
Total stockholders' equity:10,0609,242
TOTAL LIABILITIES AND EQUITY:20,70119,918

Income statement (P&L) ($ in millions)

9/30/2014
9/30/2013
Revenues
(Revenue, Net)
10,65910,235
Cost of revenue
(Cost of Goods and Services Sold)
(4,332)(4,150)
Gross profit:6,3276,085
Operating expenses(4,648)(4,175)
Other undisclosed operating income313222
Operating income:1,9922,132
Nonoperating income (expense)(14)5
Investment income, nonoperating1516
Foreign currency transaction loss, before tax(49)(32)
Other nonoperating income2089
Interest and debt expense(204)(228)
Other undisclosed income from continuing operations before equity method investments, income taxes49120
Income from continuing operations before income taxes:1,8232,029
Income tax expense(161)(429)
Net income:1,6621,600
Other undisclosed net income attributable to parent 100
Net income available to common stockholders, diluted:1,6621,700

Comprehensive Income ($ in millions)

9/30/2014
9/30/2013
Net income:1,6621,600
Comprehensive income:1,6621,600
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(147)72
Comprehensive income, net of tax, attributable to parent:1,5151,672

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: